NATCOPHARM.NSNATCOPHARM.NSNSE
Loading
EPS Diluted Over TimeContracting
Percentile Rank93
3Y CAGR+30.4%
5Y CAGR+29.2%
Studio
Year-over-Year Change

Diluted earnings per share

3Y CAGR
+30.4%/yr
vs +3.0%/yr prior
5Y CAGR
+29.2%/yr
Consistent
Acceleration
+27.5pp
Accelerating
Percentile
P93
Near historical high
vs 5Y Ago
3.6x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM86.94-17.4%
2025105.26+36.1%
202477.34+97.4%
202339.18+320.4%
20229.32-61.4%
202124.16-4.4%
202025.26-27.6%
201934.87-10.9%
201839.13+40.4%
201727.87-